JPT Peptide Technologies — Stock, Pipeline & Market Cap

Is this your company? Claim your profile to update info and connect with investors.

Private Company

Funding information not available

Overview

JPT Peptide Technologies is a Berlin-based, privately-held specialist in peptide synthesis and peptide-based research tools, operating as a critical service and product provider in the life sciences sector. The company leverages its expertise to offer a comprehensive portfolio spanning custom peptide synthesis, peptide libraries (PepTrack), peptide pools for T-cell activation (PepMix), peptide microarrays (PepStar), and proteomics standards (SpikeTides). Its business model is primarily service- and platform-based, generating revenue by supplying research tools to academic, biotech, and pharmaceutical clients engaged in immunology, oncology, infectious disease, and proteomics. JPT has established itself as a trusted partner in high-complexity peptide production and assay development over its 20-year history.

OncologyInfectious DiseasesAutoimmune DiseasesNeuroscience

Technology Platform

Integrated suite of peptide synthesis and application technologies, including custom peptide synthesis, peptide libraries (PepTrack), peptide pools for immune monitoring (PepMix), peptide microarrays (PepStar), and isotopically labeled proteomics standards (SpikeTides). Expertise in complex modifications (PTMs, cyclization, conjugations).

Opportunities

Strong growth drivers include the expansion of cancer immunotherapy and personalized vaccine development, which require precise peptide tools for epitope mapping and immune monitoring.

Additionally, the maturation of targeted mass spectrometry for clinical proteomics creates a growing market for its quantified reference peptides (SpikeTides).

Risk Factors

Faces competition from larger, diversified life science suppliers and other peptide CROs on price and scale.

Revenue is tied to biopharma R&D budgets and academic funding, which can be cyclical.

Operational execution risk in consistently delivering high-quality, complex peptides is critical to maintaining reputation.

Competitive Landscape

Competes with large reagent suppliers (e.g., Thermo Fisher, GenScript) and specialized peptide synthesis companies (e.g., Bachem, CPC Scientific). Differentiation is based on deep expertise in complex modifications, high-purity standards, and specialized product families for immunology and proteomics, rather than being the lowest-cost provider.

More companies in Proteomics & Protein Engineering →More companies in Germany →